Correction: Inferring protein modulation from gene expression data using conditional mutual information (PLoS ONE (2016) 9:10 (e109569) DOI: 10.1371/journal.pone.0109569);Inferring protein modulation from gene expression data using conditional mutual information

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Giorgi, Federico M ^a   Lopez, Gonzalo ^a   Woo, Jung H ^a   Bisikirska, Brygida ^a   Califano, Andrea ^a,b   Bansal, Mukesh ^a  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; MESSENGER RNA; PROTEIN;

ACCURACY; ARTICLE; CONDITIONAL INFERENCE OF NETWORK DYNAMICS ALGORITHM; CONTROLLED STUDY; ENTROPY; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; METHODOLOGY; MODULATION; MODULATOR INFERENCE BY NETWORK DYNAMICS ALGORITHM; MOLECULAR DYNAMICS; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ALGORITHM; BAYES THEOREM; BIOLOGICAL MODEL; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; SEQUENCE ANALYSIS; SYSTEMS BIOLOGY;

ALGORITHMS; BAYES THEOREM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; SYSTEMS BIOLOGY;

EID: 84907970841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163402     Document Type: Erratum

References (67)

1. Lefebvre C, Rieckhof G, Califano A (2012) Reverse-engineering human regulatory networks. Wiley Interdiscip Rev Syst Biol Med 4: 311-325.
2. Wang K, Saito M, Bisikirska BC, Alvarez MJ, Lim WK, et al. (2009) Genomewide identification of post-translational modulators of transcription factor activity in human B cells. Nat Biotechnol 27: 829-839.
3. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, et al. (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390.
4. Giorgi FM, Del Fabbro C, Licausi F (2013) Comparative study of RNA-seq-and Microarray-derived coexpression networks in Arabidopsis thaliana. Bioinformatics 29: 717-724.
5. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325.
6. Zhao X, D DA, Lim WK, Brahmachary M, Carro MS, et al. (2009) The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell 17: 210-221.
7. Aytes A, Mitrofanova A, Lefebvre C, Alvarez MJ, Castillo-Martin M, et al. (2014) Cross-species analysis of genome-wide regulatory networks identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell, in press.
8. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, et al. (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37: 710-717.
9. Friedman N (2004) Inferring cellular networks using probabilistic graphical models. Science 303: 799-805.
10. Zampieri M, Soranzo N, Altafini C (2008) Discerning static and causal interactions in genome-wide reverse engineering problems. Bioinformatics 24: 1510-1515.
11. Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, et al. (2004) Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 431: 308-312.
12. Wang K, Saito M, Bisikirska BC, Alvarez MJ, Lim WK, et al. (2009) Genomewide identification of post-translational modulators of transcription factor activity in human B cells. Nature biotechnology 27: 829-837.
13. Bisikirska BC, Adam SJ, Alvarez MJ, Rajbhandari P, Cox R, et al. (2012) STK38 is a critical upstream regulator of MYC's oncogenic activity in human Bcell lymphoma. Oncogene.
14. Bansal M, Califano A (2012) Genome-wide dissection of posttranscriptional and posttranslational interactions. Gene Regulatory Networks: Springer. pp. 131-149.
15. Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, et al. (2008) A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 4: 169.
16. Liang K-C, Wang X (2008) Gene regulatory network reconstruction using conditional mutual information. EURASIP Journal on Bioinformatics and Systems Biology 2008.
17. Basso K, Saito M, Sumazin P, Margolin AA, Wang K, et al. (2010) Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood 115: 975-984.
18. Hammerman P, Lawrence M, Voet D, Jing R, Cibulskis K, et al. (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519-525.
19. Prasad TK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human protein reference database-2009 update. Nucleic acids research 37: D767-D772.
20. Yu H, Tardivo L, Tam S, Weiner E, Gebreab F, et al. (2011) Next-generation sequencing to generate interactome datasets. Nature methods 8: 478-480.
21. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, et al. (2013) STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic acids research 41: D808-D815.
22. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, et al. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic acids research 40: D261-D270.
23. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, et al. (2010) ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26: 2438-2444.
24. Basso K, Saito M, Sumazin P, Margolin AA, Wang K, et al. (2010) Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood 115: 975-984.
25. Faith JJ, Hayete B, Thaden JT, Mogno I, Wierzbowski J, et al. (2007) Largescale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS biology 5: e8.
26. Villaverde AF, Ross J, Morán F, Banga JR (2014) Mider: network inference with mutual information distance and entropy reduction. PloS one 9: e96732.
27. Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, et al. (2006) ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC bioinformatics 7: S7.
28. Opgen-Rhein R, Strimmer K (2007) From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression data. BMC systems biology 1: 37.
29. Luo W, Hankenson KD, Woolf PJ (2008) Learning transcriptional regulatory networks from high throughput gene expression data using continuous three-way mutual information. BMC bioinformatics 9: 467.
30. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006) TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic acids research 34: D108-D110.
31. Fang N, Greiner T, Weisenburger D, Chan W, Vose J, et al. (2003) Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proceedings of the National Academy of Sciences of the United States of America 100: 5372-5377.
32. Al-Assar O, Rees-Unwin KS, Menasce LP, Hough RE, Goepel JR, et al. (2006) Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes. British journal of haematology 133: 612-621.
33. Dalla-Favera R, Martinotti S, Gallo RC, Erikson J, Croce CM (1983) Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219: 963-967.
34. Ott G, Rosenwald A, Campo E (2013) Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood 122: 3884-3891.
35. Evens AM, Sehn LH, Farinha P, Nelson BP, Raji A, et al. (2010) Hypoxia-Inducible Factor-1 a Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology 28: 1017-1024.
36. Qiao Q, Nozaki Y, Sakoe K, Komatsu N, Kirito K (2010) NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma. Experimental hematology 38: 1199-1208.
37. Gilmore T (1991) Role of rel family genes in normal and malignant lymphoid cell growth. Cancer surveys 15: 69-87.
38. Grimes C, Jope R (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426.
39. Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T (2009) The IKK2/NF-κB pathway suppresses MYC-induced lymphomagenesis. Blood 114: 2448-2458.
40. Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ (1992) Signal transduction within the nucleus by mitogen-activated protein kinase. Journal of Biological Chemistry 267: 24796-24804.
41. Fisher RP (2012) The CDK Network Linking Cycles of Cell Division and Gene Expression. Genes & cancer 3: 731-738.
42. Morgan DO (1995) Principles of CDK regulation. Nature 374: 131-134.
43. Obaya A, Sedivy J (2002) Regulation of cyclin-Cdk activity in mammalian cells. Cellular and Molecular Life Sciences CMLS 59: 126-142.
44. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, et al. (2004) Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer cell 6: 565-576.
45. Faber AC, Chiles TC (2007) Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas. CELL CYCLE-LANDES BIOSCIENCE- 6: 2982.
46. Junk DJ, Cipriano R, Stampfer M, Jackson MW (2013) Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells. PloS one 8: e53776.
47. Cleynen I, Van de Ven WJ (2008) The HMGA proteins: A myriad of functions (Review). International journal of oncology 32: 289-305.
48. Esposito F, Tornincasa M, Federico A, Chiappetta G, Pierantoni G, et al. (2012) High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria. Cell death & disease 3: e383.
49. Frasca F, Rustighi A, Malaguarnera R, Altamura S, Vigneri P, et al. (2006) HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer research 66: 2980-2989.
50. Giono LE, Manfredi JJ (2007) Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Molecular and cellular biology 27: 4166-4178.
51. Crescenzi E, Sannino M, Tonziello G, Palumbo G (2002) Association of Bcl-2 with Cyclin A/Cdk-2 Complex and Its Effects on Cdk-2 Activity. Annals of the New York Academy of Sciences 973: 268-271.
52. Esposito F, Tornincasa M, Chieffi P, De Martino I, Pierantoni GM, et al. (2010) High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. Cancer research 70: 5379-5388.
53. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, et al. (1995) Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. Journal of Biological Chemistry 270: 20775-20780.
54. Shao H, Cheng HY, Cook RG, Tweardy DJ (2003) Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer research 63: 3923-3930.
55. Yu Y-L, Chiang Y-J, Chen Y-C, Papetti M, Juo C-G, et al. (2005) MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. Journal of Biological Chemistry 280: 29533-29542.
56. Major ML, Lepe R, Costa RH (2004) Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Molecular and cellular biology 24: 2649-2661.
57. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, et al. (2010) A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6: 377.
58. Califano A, Butte AJ, Friend S, Ideker T, Schadt E (2012) Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat Genet 44: 841-847.
59. Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, et al. (2013) Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia. Cancer Cell 24: 766-776.
60. Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, et al. (2012) Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nat Med 18: 436-440.
61. Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer A, et al. (2011) An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma. Cell 147: 307.
62. De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, et al. (2010) The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med 16: 1321-1327.
63. Jang IS, Margolin A, Califano A (2013) hARACNe: improving the accuracy of regulatory model reverse engineering via higher-order data processing inequality tests. Interface focus 3: 20130011.
64. Matys V, Fricke E, Geffers R, Gößling E, Haubrock M, et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic acids research 31: 374-378.
65. Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, et al. (2009) AmiGO: online access to ontology and annotation data. Bioinformatics 25: 288-289.
66. Reverter A, Chan EK (2008) Combining partial correlation and an information theory approach to the reversed engineering of gene co-expression networks. Bioinformatics 24: 2491-2497.
67. Margolin AA, Wang K, Lim WK, Kustagi M, Nemenman I, et al. (2006) Reverse engineering cellular networks. Nature Protocols 1: 662-671.